MGFA Session 2025: Single dose of KYV-101 eases gMG symptoms
A single dose of KYV-101, a cell therapy being developed by Kyverna Therapeutics for generalized myasthenia gravis…
Articles by Lila Levinson, PhD
MGFA Session 2025: Telitacicept eases gMG symptoms long term
Nearly one year of treatment with Remegen’s telitacicept in a clinical trial in China led to substantial and sustained…
Vyvgart eases gMG, prevents surgery complications: Case study
Vyvgart (efgartigamod) rapidly eased symptoms of generalized myasthenia gravis (gMG) and prevented complications before, during, and after surgery in…
gMG tends to be more aggressive with onset at age 65 or older
People who begin experiencing symptoms of generalized myasthenia gravis (gMG) at the age of 65 or older tend to…
Grand Slam winner, Argenx partner on campaign raising MG awareness
Nine-time tennis Grand Slam champion Monica Seles, who has myasthenia gravis (MG), is teaming up with pharmaceutical company…
Ultomiris now closer to being covered in Canada for treating gMG
Ultomiris (ravulizumab-cwvz) is now closer to being covered by public Canadian healthcare systems when used to treat adults with…
Vyvgart found effective for 3 triple-seronegative gMG patients
Treatment with Vyvgart (efgartigimod) eased hard-to-treat symptoms for a trio of women with generalized myasthenia gravis (gMG) who…
Sex differences found in MG symptoms, surgery outcomes: Study
Women who have surgery to remove their thymus gland to treat myasthenia gravis (MG) tend to have experienced symptoms…
Vyvgart may be safer, more effective than IVIG in older patients
Vyvgart (efgartigimod alfa-fcab) may be safer and more effective than intravenous immunoglobulin (IVIG) therapy in elderly people with…
Robotic thymectomy safe, effective for treating MG: Study
Robotic thymectomy is a safe and effective treatment for people with myasthenia gravis (MG), including patient groups that…